Palonosetron Sandoz 0.25 mg / 5 ml Soluzione iniettabile Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

palonosetron sandoz 0.25 mg / 5 ml soluzione iniettabile

sandoz pharmaceuticals ag - palonosetronum - soluzione iniettabile - palonosetronum 0.05 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, natrii citras dihydricus, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.93 mg. - antiemetico - synthetika

Palonosetron Accord 0,25 mg/5 ml Soluzione iniettabile Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

palonosetron accord 0,25 mg/5 ml soluzione iniettabile

accord healthcare ag - palonosetronum - soluzione iniettabile - palonosetronum 0.05 mg ut palonosetroni hydrochloridum, mannitolum, acidum citricum monohydricum, natrii citras dihydricus, dinatrii edetas, natrii hydroxidum q.s. ad ph, acidum hydrochloridum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.6 mg. - antiemetico - synthetika

Kimmtrak Uni Eropa - Italia - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - agenti antineoplastici - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Palonosetron Labatec 0.25 mg/ 5 ml soluzione iniettabile i.v. Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

palonosetron labatec 0.25 mg/ 5 ml soluzione iniettabile i.v.

labatec pharma sa - palonosetronum - soluzione iniettabile i.v. - palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, natrii citras dihydricus, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 5 ml corresp. natrium max. 3.9 mg. - antiemetico - synthetika

Palonosetron-Teva 0.25 mg/5 ml Soluzione iniettabile Swiss - Italia - Swissmedic (Swiss Agency for Therapeutic Products)

palonosetron-teva 0.25 mg/5 ml soluzione iniettabile

teva pharma ag - palonosetronum - soluzione iniettabile - palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, acidum citricum monohydricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp., natrium 5,8 mg. - antiemetico - synthetika

PALONOSETRON REIG JOFRE Italia - Italia - AIFA (Agenzia Italiana del Farmaco)

palonosetron reig jofre

laboratorio reig jofre, s.a. - palonosetron - palonosetron